A paper given at the recent annual meeting of the American Society for Radiation Ocology (ASTRO) suggests that the Decipher genomic classifier may help to distinguish between treatment options for men in need of salvage radiation therapy after first-line radical prostatectomy. The Decipher test is a laboratory test based on analysis of post-surgical prostate cancer […]![]()
